Intra-Day Update On: (NASDAQ: ACUR), (NASDAQ: ALXA)

Publishing & Media

Share Tweet

Intra-Day Update On: (NASDAQ: ACUR), (NASDAQ: ALXA)

New York (December 21st, 2012) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse through its Aversion and Impede Technologies, is down sharply in mid-day trading today, extending its losses from the previous trading sessions. 

ACUR is currently trading 4.63% lower at $2.27 on volume of 297,948, which is well below the daily average volume of 805,619. The stock has fallen more than 12% in the last three trading sessions. 

ACUR has fallen sharply in the last three days even as the company announced that it filed an Investigational New Drug Application with the FDA to allow clinical testing of its hydrocodone bitartrate with acetaminophen formulated with Aversion® Technology. 

Find out more about ACUR by getting the free full report here:

Alexza Pharmaceuticals Inc. (NASDAQ: ALXA), a pharmaceutical company engaged in the research, development and commercialization of products for acute treatment of central nervous system (CNS) conditions, is down sharply in mid-day trading today, reversing some of the gains from Thursday’s trading session.

ALXA had rallied more than 13% on Thursday. The stock is down nearly 5% to $5.91 in trading currently on above average volume of 1.30 million. 

ALXA has been struggling to break through $6.25 resistance level. If the stock breaks through this level, a strong bullish trend will be established. 

ALXA last week announced that a European Union panel recommended approval of its Adasuve. 

Find out how this announcement could benefit ALXA by getting the free full report here:

About Us: issues momentum alerts on stocks that can provide gains to day traders and short-term investors. provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Contact Info:
Thomas Greene
Wall Street Scoop
[email protected]